LeMaitre Vascular, Inc. (LMAT)

LeMaitre Vascular trailed consensus on both revenue and EPS in the second fiscal quarter of 2026, reported Aug. 4, as revenue of $70.4 million trailed the $71.5 million estimate, -1.5%, and EPS of $0.74 trailed the $0.81 estimate, -8%. Revenue rose 9.6% year over year to about $70.4 million, while gross profit of about $50.8 million left gross margin near 72% and operating income of about $20.4 million left operating margin around 29%. Net income increased 23.7% to about $17.1 million from $13.8 million a year ago, and EPS of $0.74 was up 23.3% from $0.60. Operating cash flow came in at about $16.0 million, the company repurchased about $112,000 of stock, and it paid about $5.7 million in dividends. Next-period consensus calls for EPS of $0.69 on revenue of $67.4 million.